ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
US Tech 100
17,316.80
0.45%
Dow Jones
38,386.09
0.38%
Brent Oil
87.285
-0.45%
Bitcoin
63,768.97
1.22%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/29/20246:45PMPR Newswire (Canada)Pond Technologies Holdings Inc. Announces Filing of 2023 Audited Financial Statements and MD&ATSXV:PONDPond Technologies Holdings Inc
04/29/20246:45PMPR Newswire (US)Memorial Neuroscience Institute First in South Florida to Utilize Latest Aneurysm Treatment Technology
04/29/20246:44PMGlobeNewswire Inc.Greenland Resources Announces Voting ResultsNEO:MOLYGreenland Resources Inc
04/29/20246:43PMPR Newswire (US)Dallas Plaintiffs Law Firm Hamilton Wingo Wins $6 Million Verdict for Walmart Auto Care Center Customer
04/29/20246:42PMBusiness WireKBRA Assigns AAA Rating, Stable Outlook to County of Buncombe Taxable General Obligation Housing Bonds, Series 2024; Limited Obligation Bonds Rated AA+
04/29/20246:41PMPR Newswire (Canada)Canadian Utilities to Share Strategic Update at Annual General Meeting on May 8, 2024TSX:CUCanadian Utilities Limited
04/29/20246:40PMBusiness WireFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerNASDAQ:GMABGenmab AS
04/29/20246:40PMBusiness WireFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
04/29/20246:40PMBusiness WireTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
04/29/20246:40PMBusiness WireTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerNASDAQ:GMABGenmab AS
04/29/20246:40PMGlobeNewswire Inc.TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerNASDAQ:GENGen Digital Inc
04/29/20246:40PMGlobeNewswire Inc.TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer0MGB
04/29/20246:40PMGlobeNewswire Inc.TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerTG:GE9Genmab AS
04/29/20246:38PMGlobeNewswire Inc.Vistar Media Acquires ADstruc, Adding Traditional OOH Planning and Buying Software to Complete Full Suite for Buyers
04/29/20246:31PMGlobeNewswire Inc.MercadoLibre, Inc. to Report First Quarter 2024 Financial ResultsNASDAQ:MELIMercadoLibre Inc
04/29/20246:31PMBusiness WireAir Lease Corporation Increases Senior Unsecured Revolving Credit Facility to $7.8 BillionNYSE:ALAir Lease Corporation
04/29/20246:30PMGlobeNewswire Inc.Five Star Bancorp Announces First Quarter 2024 ResultsNASDAQ:FSBCFive Star Bancorp
04/29/20246:30PMGlobeNewswire Inc.Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & EndocrinologyNASDAQ:RYTMRhythm Pharmaceuticals Inc
04/29/20246:29PMPR Newswire (Canada)Déclaration - Le ministre LeBlanc accueille la nomination de Mike Duheme au poste de commissaire de la Gendarmerie royale du Canada
04/29/20246:26PMPR Newswire (Canada)RYAM suspend les activités de l'usine de cellulose de haute pureté de Témiscaming pour une durée indéfinieNYSE:RYAMRayonier Advanced Materials Inc
04/29/20246:25PMPR Newswire (Canada)RYAM to Suspend Temiscaming High Purity Cellulose Plant Operations for an Indefinite PeriodNYSE:RYAMRayonier Advanced Materials Inc
04/29/20246:24PMGlobeNewswire Inc.Hammond Power Solutions Reports First Quarter 2024 Financial ResultsHPS-A
04/29/20246:24PMGlobeNewswire Inc.Hammond Power Solutions Reports First Quarter 2024 Financial ResultsHPS-A.TO
04/29/20246:21PMPR Newswire (Canada)Statement - Minister LeBlanc welcomes appointment of Mike Duheme as Commissioner of the Royal Canadian Mounted Police
04/29/20246:20PMPR Newswire (US)M&T Bank Corporation to Participate in the Barclays Americas Select Franchise ConferenceNYSE:MTBM and T Bank Corporation
04/29/20246:19PMPR Newswire (US)Itaú Unibanco Holding's 2023 Annual Report on Form 20-F filed with the SEC and the CVMNYSE:ITUBItau Unibanco Holding SA
04/29/20246:18PMPR Newswire (Canada)OverActive Media Reports Record Revenues and Solid Earnings Growth in 2023TSXV:OAMOveractive Media Corp
04/29/20246:09PMGlobeNewswire Inc.DIH Announces Fiscal 2024 Financial Results for the Nine Months Ended December 31, 2023NASDAQ:DHAIDIH Holdings US Inc
04/29/20246:09PMPR Newswire (Canada)Nomination de la présidente et chef de la direction de Santé Québec; réaction de la FTQ
04/29/20246:09PMPR Newswire (Canada)ATCO Ltd. to Share Strategic Update at Annual General Meeting on May 15, 2024TSX:ACO.XATCO Ltd

Your Recent History

USOTC
RONN
Ronn Motor (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
ACRL
Atacama Resources (PK)
USOTC
ILST
International Star (PK)
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
PLUG
Plug Power
USOTC
TONR
Tonner One World (PK)
USOTC
CNNA
Cann American (CE)
COIN
SHIBUSD
SHIBA INU
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
NB
NioCorp Developments
USOTC
DKSC
Dakshidin (PK)
USOTC
RDGL
Vivos (QB)
USOTC
EPAZ
Epazz (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
GVSI
Good Vibrations Shoes (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved